Literature DB >> 21562908

[Mirtazapine and hyperemesis gravidarum].

M Lieb1, U Palm, D Jacoby, T C Baghai, E Severus.   

Abstract

The case of a 29-year-old patient in the 21st gestational week with severe hyperemesis gravidarum which did not respond to conventional antiemetic treatment is reported. Nausea and vomiting improved within 48 h after i.v. administration of 30 mg mirtazapine/day. The pathophysiological and therapeutic implications are discussed.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21562908     DOI： 10.1007/s00115-011-3297-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


  13 in total

1.  Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature.

Authors:  Serkan Guclu; Mert Gol; Erbil Dogan; Ugur Saygili
Journal:  Arch Gynecol Obstet       Date:  2005-10-13       Impact factor: 2.344

2.  Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.

Authors:  Josephine Djulus; Gideon Koren; Thomas R Einarson; Lynda Wilton; Saad Shakir; Orna Diav-Citrin; Deborah Kennedy; Sharon Voyer Lavigne; Marco De Santis; Adrienne Einarson
Journal:  J Clin Psychiatry       Date:  2006-08       Impact factor: 4.384

3.  Maternal and fetal outcomes in hyperemesis gravidarum.

Authors:  I S Tsang; V L Katz; S D Wells
Journal:  Int J Gynaecol Obstet       Date:  1996-12       Impact factor: 3.561

Review 4.  A review of the pharmacological and clinical profile of mirtazapine.

Authors:  S A Anttila; E V Leinonen
Journal:  CNS Drug Rev       Date:  2001

5.  Anxiety and depression in hyperemesis gravidarum: prevalence, risk factors and correlation with clinical severity.

Authors:  Peng Chiong Tan; Subramaniam Vani; Boon Kiong Lim; Siti Zawiah Omar
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2010-01-25       Impact factor: 2.435

Review 6.  Chicken or the egg? The biological-psychological controversy surrounding hyperemesis gravidarum.

Authors:  Shari Munch
Journal:  Soc Sci Med       Date:  2002-10       Impact factor: 4.634

7.  Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy.

Authors:  Anke Rohde; Joerg Dembinski; Christoph Dorn
Journal:  Arch Gynecol Obstet       Date:  2003-06-18       Impact factor: 2.344

8.  Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.

Authors:  R E Kast; K F Foley
Journal:  Eur J Cancer Care (Engl)       Date:  2007-07       Impact factor: 2.520

9.  Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine.

Authors:  V Schwarzer; A Heep; U Gembruch; A Rohde
Journal:  Arch Gynecol Obstet       Date:  2007-07-13       Impact factor: 2.344

10.  Hyperemesis during pregnancy and delivery outcome: a registry study.

Authors:  B Källén
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1987-12       Impact factor: 2.435
View more
  2 in total

1.  Use of Mirtazapine and Olanzapine in the Treatment of Refractory Hyperemesis Gravidarum: A Case Report and Systematic Review.

Authors:  Marco Aurélio Knippel Galletta; Vera Lucia Carvalho Tess; Isabela Marangon Pasotti; Luiza Fior Pelegrini; Nicole Kemberly Ribeiro Rocha; Carolina Burgarelli Testa; Rossana Pulcineli Vieira Francisco
Journal:  Case Rep Obstet Gynecol       Date:  2022-09-05

2.  Validating the effect of Ondansetron and Mirtazapine In Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial.

Authors:  Anne Ostenfeld; Tonny Studsgaard Petersen; Tina Bergmann Futtrup; Jon Trærup Andersen; Andreas Kryger Jensen; Hanne Brix Westergaard; Lars Henning Pedersen; Ellen Christine Leth Løkkegaard
Journal:  BMJ Open       Date:  2020-03-24       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.